טוען...
Clopidogrel Resistance in Lower Extremity Arterial Endovascular Interventions
Antiplatelet pharmacotherapy for endovascular interventions has been widely adopted, with clopidogrel being one of the most common agents prescribed. A fraction of patients is resistant to clopidogrel resulting in decreased platelet inhibition despite adequate use. This finding is often termed high...
שמור ב:
| הוצא לאור ב: | Curr Pharm Des |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7906771/ https://ncbi.nlm.nih.gov/pubmed/30621557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1381612825666190101111123 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|